Megan Eshbaugh, DO
Rheumatology · Suffolk, VANPI 1710137096
Payments from drug & device makers
Across 942 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$2K
- Johnson & Johnson$2K
- Pfizer$1K
- UCB, Inc.$1K
- Novartis$1K
- plus $6K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 180 | $3,823 |
| AbbVie | 138 | $2,307 |
| Johnson & Johnson | 84 | $1,504 |
| Pfizer | 112 | $1,431 |
| UCB, Inc. | 80 | $1,208 |
| Novartis | 48 | $1,095 |
| E.r. Squibb & Sons, L.L.C. | 50 | $913 |
| Radius Health, Inc. | 39 | $781 |
| AstraZeneca(2 entities) | 29 | $602 |
| GSK | 33 | $532 |
| Lilly USA, LLC | 24 | $454 |
| Boehringer Ingelheim | 16 | $419 |
| Bristol Myers Squibb | 16 | $304 |
| Genentech USA, Inc. | 16 | $232 |
| Mallinckrodt Hospital Products Inc. | 9 | $207 |
| Aurinia Pharma U.S., Inc. | 11 | $202 |
| Fresenius Kabi USA, LLC | 10 | $184 |
| Ferring Pharmaceuticals Inc. | 5 | $92 |
| ANI Pharmaceuticals, Inc. | 4 | $88 |
| Actelion Pharmaceuticals US, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Organon | 3 | $64 |
| Sobi, Inc | 3 | $62 |
| Sanofi | 3 | $58 |
| Sandoz | 3 | $57 |
| Hikma Pharmaceuticals USA | 4 | $53 |
| Almatica Pharma LLC | 2 | $49 |
| Mallinckrodt Enterprises LLC | 2 | $46 |
| Mylan Institutional Inc. | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
How this compares
$17,097 in reported general payments places this provider in the 80th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Suffolk
- Jane DerrigSuffolk$23K
- John MansoorSuffolk$13K
- Julianne OrlowskiSuffolk$10K
- Peter LipskyCharlottesville$1.6M
- Sharukh ShroffDanville$1.5M
- Kristi MizelleNewport News$1.2M
- Phillip KempfArlington$467K
- Adegbenga BankoleRoanoke$355K
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.